Literature DB >> 16708058

Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Anthony E Fiore, Annemarie Wasley, Beth P Bell.   

Abstract

Routine vaccination of children is an effective way to reduce hepatitis A incidence in the United States. Since licensure of hepatitis A vaccine during 1995-1996, the hepatitis A childhood immunization strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest disease rates and continuing in 1999 with ACIP's recommendations for vaccination of children living in states, counties, and communities with consistently elevated hepatitis A rates. These updated recommendations represent the final step in the childhood hepatitis A immunization strategy, routine hepatitis A vaccination of children nationwide. Implementation of these recommendations will reinforce existing vaccination programs, extend the benefits associated with hepatitis A vaccination to the rest of the country, and create the foundation for eventual consideration of elimination of indigenous hepatitis A virus transmission. This report updates ACIP's 1999 recommendations concerning the prevention of hepatitis A through immunization (CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 1999:48[No. RR-12]:1-37) and includes 1) new data on the epidemiology of hepatitis A in the era of hepatitis A vaccination of children in selected U.S. areas, 2) results of analyses of the economics of nationwide routine vaccination of children, and 3) recommendations for the routine vaccination of children in the United States. Previous recommendations for vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A are unchanged from the 1999 recommendations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708058

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  170 in total

1.  Hepatitis a epidemiology goes global.

Authors:  Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

2.  Hepatitis A Infections Among Food Handlers in the United States, 1993-2011.

Authors:  Umid M Sharapov; Karine Kentenyants; Justina Groeger; Henry Roberts; Scott D Holmberg; Melissa G Collier
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

3.  Physician Knowledge and Attitudes About Hepatitis A and Current Practices Regarding Hepatitis A Vaccination Delivery.

Authors:  Noele P Nelson; Mandy A Allison; Megan C Lindley; Michaela Brtnikova; Lori A Crane; Brenda L Beaty; Laura P Hurley; Allison Kempe
Journal:  Acad Pediatr       Date:  2017-01-09       Impact factor: 3.107

4.  Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus.

Authors:  Anne C Moorman; Jian Xing; Noele P Nelson
Journal:  Gastroenterology       Date:  2018-05-03       Impact factor: 22.682

5.  Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds.

Authors:  Bart Van Droogenbroeck; Jingyuan Cao; Johannes Stadlmann; Friedrich Altmann; Sarah Colanesi; Stefan Hillmer; David G Robinson; Els Van Lerberge; Nancy Terryn; Marc Van Montagu; Mifang Liang; Ann Depicker; Geert De Jaeger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

6.  An outbreak of hepatitis A among primary and secondary contacts of an international adoptee.

Authors:  Andrew R Pelletier; Puja J Mehta; Donald R Burgess; Lisa M Bondeson; Patty J Carson; Vicki E Rea; Umid M Sharapov; Dale J Hu
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

7.  Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.

Authors:  Xin Yue; Carla L Black; Alissa O'Halloran; Peng-Jun Lu; Walter W Williams; Noele P Nelson
Journal:  Vaccine       Date:  2018-02-21       Impact factor: 3.641

8.  A case of acute hepatitis A infection in an HIV-positive patient despite complete hepatitis A vaccination.

Authors:  Carlos Fritzsche; M Loebermann; E C Reisinger
Journal:  Infection       Date:  2018-03-14       Impact factor: 3.553

9.  Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.

Authors:  Holly C Groom; Ning Smith; Stephanie A Irving; Padma Koppolu; Gabriela Vazquez-Benitez; Elyse O Kharbanda; Matthew F Daley; James G Donahue; Darios Getahun; Lisa A Jackson; Nicola P Klein; Natalie L McCarthy; James D Nordin; Lakshmi Panagiotakopoulos; Allison L Naleway
Journal:  Vaccine       Date:  2019-09-20       Impact factor: 3.641

10.  Distribution of hepatitis A antibodies in US blood donors.

Authors:  Alexandra Tejada-Strop; Mohammad Zafrullah; Saleem Kamili; Susan L Stramer; Michael A Purdy
Journal:  Transfusion       Date:  2018-10-04       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.